Rachel Kremen
Journalist
Freelance
From this contributor
Funds add up for research plans that put focus on families
With billions of dollars in hand, a novel initiative is funding projects that involve people with disorders and their caregivers from the outset.
Funds add up for research plans that put focus on families
Companies see upside of hiring people with autism
As the prevalence of autism grows, several companies are launching employment programs for people on the spectrum.
Standard tests underestimate nonverbal children with autism
Tests that play to the strengths of nonverbal children with autism reveal the true intellect of those considered ‘low-functioning.’
Standard tests underestimate nonverbal children with autism
Explore more from The Transmitter
Exclusive: Brain and spinal cord institute halts research, citing funding problems
The Burke Neurological Institute, which calls itself “the only research institute in the U.S. dedicated to finding treatments to repair the brain and spinal cord,” ceased research operations on 22 May.
Exclusive: Brain and spinal cord institute halts research, citing funding problems
The Burke Neurological Institute, which calls itself “the only research institute in the U.S. dedicated to finding treatments to repair the brain and spinal cord,” ceased research operations on 22 May.
When autistic kids grow up, Chapter 1: Those people
What leads an autism researcher to publish an intentionally inflammatory paper accusing the NIH of discrimination?
When autistic kids grow up, Chapter 1: Those people
What leads an autism researcher to publish an intentionally inflammatory paper accusing the NIH of discrimination?
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.